SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 37.20 |
| Enterprise Value ($M) | 235.60 |
| Book Value ($M) | -186.02 |
| Book Value / Share | -22.10 |
| Price / Book | -0.20 |
| NCAV ($M) | 0.00 |
| NCAV / Share | 0.00 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.93 |
| Return on Assets (ROA) | -0.37 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | -0.05 |
| Current Ratio | 1.70 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | n/a |
| Assets | n/a |
| Liabilities | n/a |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | n/a |
| Operating Income | -119.44 |
| Net Income | n/a |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -127.49 |
| Cash from Investing | n/a |
| Cash from Financing | 41.65 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Affinity Asset Advisors, LLC | 7.83 | ||
| 13G | Adage Capital Management, L.P. | 5.18 | ||
| 13G/A | Avidity Partners Management LP | 3.70 | -57.63 | |
| 13G/A | Vanguard Group Inc | 6.13 | 0.00 | |
| 13G | Highbridge Capital Management Llc | 7.20 | ||
| 13G/A | BlackRock, Inc. | 3.50 | -58.60 | |
| 13G | J. Wood Capital Advisors Llc | 5.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 25,688 | 70,247 | 36.57 | |
| 54,958 | 92,467 | 59.44 | |
| 23,501 | 41,306 | 56.89 | |
| 133,560 | 171,622 | 77.82 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| JAZZ – Jazz Pharmaceuticals plc | KMDA – Kamada Ltd. |
| KNSA – Kiniksa Pharmaceuticals, Ltd. | KRON – Kronos Bio, Inc. |
| KRYS – Krystal Biotech, Inc. |
Financial data and stock pages provided by
Fintel.io